Mir143 (microRNA 143) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Mir143 (microRNA 143) Rattus norvegicus
Symbol: Mir143
Name: microRNA 143
RGD ID: 2325566
Description: Predicted to enable mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including negative regulation of fat cell differentiation; response to ischemia; and response to muscle activity. Predicted to be located in extracellular exosome and synapse. Orthologous to human MIR143 (microRNA 143); INTERACTS WITH aflatoxin B1; atrazine; bis(2-ethylhexyl) phthalate.
Type: ncrna (Ensembl: miRNA)
Previously known as: microRNA mir-143; rno-mir-143
RGD Orthologs
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21855,101,006 - 55,101,110 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1855,101,006 - 55,101,110 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1857,194,722 - 57,194,826 (-)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01857,909,333 - 57,909,437 (-)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01855,724,872 - 55,724,976 (-)NCBIRnor_WKY
Rnor_6.01856,971,273 - 56,971,377 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1856,971,273 - 56,971,377 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01856,200,186 - 56,200,290 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1853,251,504 - 53,251,608 (-)NCBICelera
Cytogenetic Map18q12.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function


References - curated
# Reference Title Reference Citation
1. MicroRNA-143 regulates adipogenesis by modulating the MAP2K5-ERK5 signaling. Chen L, etal., Sci Rep. 2014 Jan 22;4:3819. doi: 10.1038/srep03819.
2. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Deng L, etal., Circ Res. 2015 Oct 23;117(10):870-83. doi: 10.1161/CIRCRESAHA.115.306806. Epub 2015 Aug 26.
3. PVT1 regulates inflammation and cardiac function via the MAPK/NF-κB pathway in a sepsis model. Feng F, etal., Exp Ther Med. 2018 Dec;16(6):4471-4478. doi: 10.3892/etm.2018.6814. Epub 2018 Oct 1.
4. Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Fernandes T, etal., Hypertension. 2011 Aug;58(2):182-9. doi: 10.1161/HYPERTENSIONAHA.110.168252. Epub 2011 Jun 27.
5. Long Non-coding RNA MALAT1/microRNA-143/VEGFA Signal Axis Modulates Vascular Endothelial Injury-Induced Intracranial Aneurysm. Gao G, etal., Nanoscale Res Lett. 2020 Jun 29;15(1):139. doi: 10.1186/s11671-020-03357-2.
6. MicroRNA-143 promotes cardiac ischemia-mediated mitochondrial impairment by the inhibition of protein kinase Cepsilon. Hong H, etal., Basic Res Cardiol. 2017 Sep 8;112(6):60. doi: 10.1007/s00395-017-0649-7.
7. Associations Between miRNAs and Two Different Cancers: Breast and Colon. Kundaktepe BP, etal., Cancer Manag Res. 2020 Feb 7;12:871-879. doi: 10.2147/CMAR.S227628. eCollection 2020.
8. MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling. Lai VK, etal., Cell Cycle. 2012 Feb 15;11(4):767-77. doi: 10.4161/cc.11.4.19211.
9. P38 MAPK Signaling Pathway Mediates Angiotensin II-Induced miR143/145 Gene Cluster Downregulation during Aortic Dissection Formation. Li B, etal., Ann Vasc Surg. 2017 Apr;40:262-273. doi: 10.1016/j.avsg.2016.09.016. Epub 2017 Feb 4.
10. MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2). Li S, etal., Front Oncol. 2019 Jun 12;9:495. doi: 10.3389/fonc.2019.00495. eCollection 2019.
11. MicroRNA-143 Increases Oxidative Stress and Myocardial Cell Apoptosis in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity. Li XQ, etal., Med Sci Monit. 2020 Mar 14;26:e920394. doi: 10.12659/MSM.920394.
12. A Smooth Muscle Cell-Enriched Long Noncoding RNA Regulates Cell Plasticity and Atherosclerosis by Interacting With Serum Response Factor. Ni H, etal., Arterioscler Thromb Vasc Biol. 2021 Sep;41(9):2399-2416. doi: 10.1161/ATVBAHA.120.315911. Epub 2021 Jul 22.
13. Identification of a novel salivary biomarker miR-143-3p for periodontal diagnosis: A proof of concept study. Nisha KJ, etal., J Periodontol. 2019 Oct;90(10):1149-1159. doi: 10.1002/JPER.18-0729. Epub 2019 May 10.
14. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
15. Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Ribeiro-Rodrigues TM, etal., Cardiovasc Res. 2017 Sep 1;113(11):1338-1350. doi: 10.1093/cvr/cvx118.
16. MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells. Wang J, etal., Sci Rep. 2018 May 4;8(1):7055. doi: 10.1038/s41598-018-25489-3.
17. The miR-143/145 cluster reverses the regulation effect of KLF5 in smooth muscle cells with proliferation and contractility in intracranial aneurysm. Xu J, etal., Gene. 2018 Dec 30;679:266-273. doi: 10.1016/j.gene.2018.09.010. Epub 2018 Sep 7.
18. Acupuncture attenuates cognitive impairments in vascular dementia through inhibiting miR-143-3p. Yang R, etal., Acta Biochim Pol. 2022 Dec 2;69(4):805-810. doi: 10.18388/abp.2020_6132.
19. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease. Yu ZH, etal., Eur J Med Res. 2017 Jan 5;22(1):2. doi: 10.1186/s40001-016-0240-y.
20. Downregulation of miR143/145 gene cluster expression promotes the aortic media degeneration process via the TGF-β1 signaling pathway. Zhang M and Wang Z, Am J Transl Res. 2019 Jan 15;11(1):370-378. eCollection 2019.
Additional References at PubMed
PMID:16381832   PMID:16766679   PMID:18556655   PMID:18791161   PMID:19188425   PMID:19816508   PMID:20403161   PMID:20489207   PMID:21441927   PMID:22897173   PMID:24166492   PMID:25486623  
PMID:25766280   PMID:25959411   PMID:26164754   PMID:28260163   PMID:28522551   PMID:29925839   PMID:30203887   PMID:30575923   PMID:30987676   PMID:30998966   PMID:31425342   PMID:31758917  
PMID:32188276   PMID:33204336   PMID:33591946   PMID:33660186   PMID:33850470   PMID:34166712   PMID:34435328   PMID:35363088  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21855,101,006 - 55,101,110 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1855,101,006 - 55,101,110 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1857,194,722 - 57,194,826 (-)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01857,909,333 - 57,909,437 (-)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01855,724,872 - 55,724,976 (-)NCBIRnor_WKY
Rnor_6.01856,971,273 - 56,971,377 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1856,971,273 - 56,971,377 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01856,200,186 - 56,200,290 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1853,251,504 - 53,251,608 (-)NCBICelera
Cytogenetic Map18q12.1NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh385149,428,918 - 149,429,023 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl5149,428,918 - 149,429,023 (+)EnsemblGRCh38hg38GRCh38
GRCh375148,808,481 - 148,808,586 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 365148,788,673 - 148,788,778 (+)NCBINCBI36Build 36hg18NCBI36
Celera5144,890,461 - 144,890,566 (+)NCBICelera
Cytogenetic Map5q32NCBI
HuRef5143,954,817 - 143,954,922 (+)NCBIHuRef
CHM1_15148,240,915 - 148,241,020 (+)NCBICHM1_1
T2T-CHM13v2.05149,963,763 - 149,963,868 (+)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm391861,782,267 - 61,782,329 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1861,782,267 - 61,782,329 (-)EnsemblGRCm39 Ensembl
GRCm381861,649,196 - 61,649,258 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1861,649,196 - 61,649,258 (-)EnsemblGRCm38mm10GRCm38
MGSCv371861,808,850 - 61,808,912 (-)NCBIGRCm37MGSCv37mm9NCBIm37
Celera1862,931,991 - 62,932,053 (-)NCBICelera
Cytogenetic Map18E1NCBI
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.1459,534,535 - 59,534,589 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl459,534,535 - 59,534,594 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha459,299,832 - 59,299,886 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0460,017,094 - 60,017,148 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl460,017,094 - 60,017,153 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1459,803,989 - 59,804,043 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0459,918,447 - 59,918,501 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0460,448,995 - 60,449,049 (-)NCBIUU_Cfam_GSD_1.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl2150,578,738 - 150,578,817 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.12150,578,738 - 150,578,817 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.22157,344,738 - 157,344,817 (+)NCBISscrofa10.2Sscrofa10.2susScr3

miRNA Target Status

Predicted Targets
Summary Value
Count of predictions:17564
Count of gene targets:8367
Count of transcripts:9079
Interacting mature miRNAs:rno-miR-143-3p, rno-miR-143-5p
Prediction methods:Microtar, Miranda, Pita, Pita,Targetscan, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2299160Iddm35Insulin dependent diabetes mellitus QTL 352.79blood glucose amount (VT:0000188)age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140)18420794160377792Rat
2293708Bss46Bone structure and strength QTL 468.80.0001lumbar vertebra morphology trait (VT:0010494)lumbar vertebra cortical cross-sectional area (CMO:0001690)181179151863636873Rat
1578661Bss20Bone structure and strength QTL 203.7femur morphology trait (VT:0000559)femoral neck cross-sectional area (CMO:0001697)181179151883218561Rat
1578667Bss21Bone structure and strength QTL 213.5femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)181179151883218561Rat
1358358Sradr6Stress Responsive Adrenal Weight QTL 62.49adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)181194429959330563Rat
6903359Bp355Blood pressure QTL 3553.6arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)181194454459796478Rat
2313082Bss85Bone structure and strength QTL 850.80.0001long bone metaphysis morphology trait (VT:0000133)tibia midshaft total cross-sectional area (CMO:0001715)181495133759951337Rat
1358193Emca2Estrogen-induced mammary cancer QTL 21.6mammary gland integrity trait (VT:0010552)post-insult time to mammary tumor formation (CMO:0000345)181800759963571040Rat
1600373Mamtr6Mammary tumor resistance QTL 6mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)181927890183218561Rat
1331741Bp232Blood pressure QTL 2323.59112arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)182137289383213037Rat
1331733Bp233Blood pressure QTL 2333.97196arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182479697779788953Rat
2325839Bp348Blood pressure QTL 3480.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182557098570570985Rat
2293704Bss35Bone structure and strength QTL 354.590.0002femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)182896485373964853Rat
2300157Bmd66Bone mineral density QTL 6613.10.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)182896485373964853Rat
2300177Bmd65Bone mineral density QTL 6519.70.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)182896485373964853Rat
9589816Gluco68Glucose level QTL 687.250.001blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)182979296574792965Rat
8694378Bw157Body weight QTL 1573.590.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)182979296574792965Rat
9590318Scort22Serum corticosterone level QTL 227.640.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)182979296574792965Rat
1331754Bp230Blood pressure QTL 2304.61609arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182979296574792965Rat
738005Anxrr11Anxiety related response QTL 113.4exploratory behavior trait (VT:0010471)number of entries into a discrete space in an experimental apparatus (CMO:0000960)183003981375039813Rat
61383Bp47Blood pressure QTL 4717.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)183127168160377755Rat
1331742Bp228Blood pressure QTL 2283.88752arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331774Bp226Blood pressure QTL 2264.41065arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331776Bp225Blood pressure QTL 2252.829arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)183135940859796643Rat
1331798Bp224Blood pressure QTL 2243.53873arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331727Bp237Blood pressure QTL 2373.053arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940861698465Rat
61429Cia17Collagen induced arthritis QTL 174.6joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)183135940870263868Rat
2303120Mamtr8Mammary tumor resistance QTL 80.001mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)183135940883218561Rat
6903347Bp350Blood pressure QTL 3504.4arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135953059796478Rat
631274Sprol1Serum protein level QTL 15.3blood total protein amount (VT:0005567)serum total protein level (CMO:0000661)183139332077209694Rat
631518Bw11Body weight QTL 112.8body mass (VT:0001259)body weight (CMO:0000012)183587072380870723Rat
61367Iddm4Insulin dependent diabetes mellitus QTL 42.330.0074blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)183819245583192455Rat
1598826Anxrr20Anxiety related response QTL 203.04body movement coordination trait (VT:0005424)number of rearing movements in an experimental apparatus (CMO:0001752)184143297183828827Rat
6893683Bw110Body weight QTL 1102.70.002body mass (VT:0001259)body weight (CMO:0000012)184334502283828827Rat
8694366Abfw8Abdominal fat weight QTL 86.380.001visceral adipose mass (VT:0010063)abdominal fat pad weight to body weight ratio (CMO:0000095)184664067583828827Rat
8694432Bw165Body weight QTL 1653.810.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)184664067583828827Rat
9589041Epfw12Epididymal fat weight QTL 1217.080.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)184664067583828827Rat
1331806Bp229Blood pressure QTL 2294.36484arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671876357867167Rat
1331736Bp227Blood pressure QTL 2272.791arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)184671876359796643Rat
1331780Bp238Blood pressure QTL 2383.269arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671876359796643Rat
6903345Bp349Blood pressure QTL 3493.9arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
6903349Bp351Blood pressure QTL 3513.5arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
6903351Bp352Blood pressure QTL 3523.3arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
61360EaeyExperimental allergic encephalomyelitis QTL y3nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis duration (CMO:0001424)184698893960377753Rat
2303571Bw92Body weight QTL 923body mass (VT:0001259)body weight (CMO:0000012)184852004483828827Rat
2303584Gluco55Glucose level QTL 552blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)184852004483828827Rat
7411719Strs5Sensitivity to stroke QTL 59.4cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)184999995865845095Rat
2293658Bmd23Bone mineral density QTL 237.30.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)185146473363636873Rat
738008Hcar14Hepatocarcinoma resistance QTL 144.3liver integrity trait (VT:0010547)liver nonremodeling tumorous lesion number (CMO:0001462)185146473383218561Rat
1331730Scl27Serum cholesterol level QTL 273.826blood HDL cholesterol amount (VT:0000184)serum high density lipoprotein cholesterol level (CMO:0000361)185229287559796643Rat
1331752Bw27Body weight QTL 272.963body mass (VT:0001259)body weight (CMO:0000012)185229287565845095Rat
1359020Ppulsi2Prepulse inhibition QTL 22.71prepulse inhibition trait (VT:0003088)acoustic startle response measurement (CMO:0001519)185229287573997283Rat
1600375Mcs22Mammary carcinoma susceptibility QTL 223.3mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)185253976363933058Rat
631509Sald2Serum aldosterone level QTL 22.9blood aldosterone amount (VT:0005346)serum aldosterone level (CMO:0000487)185253976369140759Rat
12880368Bw187Body weight QTL 1870.045body mass (VT:0001259)body weight (CMO:0000012)185253976376104388Rat
12904067Cm122Cardiac mass QTL 1220.001heart mass (VT:0007028)heart wet weight to body weight ratio (CMO:0002408)185253976376104388Rat
12904069Cm123Cardiac mass QTL 1230.001heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)185253976376104388Rat
12904070Cm124Cardiac mass QTL 1240.01heart right ventricle mass (VT:0007033)heart right ventricle weight to body weight ratio (CMO:0000914)185253976376104388Rat
12904071Am18Aortic mass QTL 180.001aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)185253976376104388Rat
12904073Kidm71Kidney mass QTL 710.001kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)185253976376104388Rat
2301417Bp319Blood pressure QTL 3190.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)185253976376104388Rat
1300125Rf26Renal function QTL 263.2urine potassium amount (VT:0010539)urine potassium excretion rate (CMO:0000761)185253986365844950Rat
1298072Cia26Collagen induced arthritis QTL 263.6joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)185470976983828827Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21855,102,714 - 55,102,886 (+)MAPPERmRatBN7.2
Rnor_6.01856,972,982 - 56,973,153NCBIRnor6.0
Rnor_5.01856,201,895 - 56,202,066UniSTSRnor5.0
RGSC_v3.41857,626,822 - 57,626,993UniSTSRGSC3.4
Celera1853,253,213 - 53,253,384UniSTS
RH 3.4 Map18542.0UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 1 2 1 1 1 2 12 10 1
Low 2 41 25 9 18 9 7 9 22 24 21 1 7
Below cutoff 4 4 4 6 6 4


Nucleotide Sequences
RefSeq Transcripts NR_031889 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide JACYVU010000301 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENSRNOT00000053726
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1855,101,006 - 55,101,110 (-)Ensembl
Rnor_6.0 Ensembl1856,971,273 - 56,971,377 (-)Ensembl
RefSeq Acc Id: NR_031889
Rat AssemblyChrPosition (strand)Source
mRatBN7.21855,101,006 - 55,101,110 (-)NCBI
Rnor_6.01856,971,273 - 56,971,377 (-)NCBI
Rnor_5.01856,200,186 - 56,200,290 (-)NCBI
Celera1853,251,504 - 53,251,608 (-)NCBI

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2325566 AgrOrtholog
BioCyc Gene G2FUF-7307 BioCyc
Ensembl Genes ENSRNOG00000035603 Ensembl, ENTREZGENE
Ensembl Transcript ENSRNOT00000053726 ENTREZGENE
miRBase MI0000916 ENTREZGENE
NCBI Gene 100314035 ENTREZGENE
PhenoGen Mir143 PhenoGen
RNAcentral URS0000365CE3 RNACentral
  URS000055F35D RNACentral
  URS000075DBC2 RNACentral

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2013-08-14 Mir143  microRNA 143  Mir143  microRNA mir-143  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2010-06-02 Mir143  microRNA mir-143      Symbol and Name status set to provisional 70820 PROVISIONAL